EUDAW (EUDAW) Stock Price & Analysis
EUDAW (EUDAW) closed at USD 0.03 on Thursday, October 15, 2026, up 14.22% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.03; the Oct 15, 2026 session ranged USD 0.03–0.03 on volume of 912 shares. Market capitalization is —, with a 52-week range of USD 0.03–0.03 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/EUDAW.md
Key facts (EUDAW)
- Analysts: None.
Analysts (EUDAW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 14.22% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.03 |
| Day Range | USD 0.03 – 0.03 |
| 52-Week Range | USD 0.03 – 0.03 |
| Volume | 912 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (EUDAW)
Wall Street analysts rate EUDAW "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Financial Health Score (EUDAW)
Nexqual rates EUDAW's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Strong — Revenue +70% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $366K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$2M (TTM) |
| Efficiency | Critical — ROE -211%, ROA -21.9% |
Leadership (EUDAW)
EUDAW is led by Alfred Lim (age 73), CEO & Executive Director, per Nexqual as of October 16, 2026 at 05:11 UTC.
| CEO & Executive Director | Alfred Lim (age 73) |
|---|---|
| Chief Technology Officer | Daniel Tan (age 43) |
| Interim Chief Financial Officer | Whye Shin Tay (age 39) |
| Operational Director | Aaron Lim |
| Managing Director of EUDA Health Malaysia Sdn Bhd | Johnson Tang |
Major Backers & Investors (EUDAW)
Notable institutional backers of EUDAW include LMR Partners LLP, Shaw D.E. & Co., Inc., RiverNorth Capital Management, LLC, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| LMR Partners LLP | 3.34% |
| Shaw D.E. & Co., Inc. | 2.23% |
| RiverNorth Capital Management, LLC | 1.93% |
| Yakira Capital Management, Inc. | 0.97% |
| RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc | 0.61% |
| RIVERNORTH/DOUBLELINE STRATEGIC OPPORTUNITY Fd. INC.-Rivernorth/Double | 0.57% |
| Wolverine Asset Management, LLC | 0.26% |
| Susquehanna International Group, LLP | 0.15% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EUDA | Euda Health Holdings Limited | USD 15.49 | ▼ 8.93% |
| DRTSW | Alpha Tau Medical Ltd. Warrant | USD 2.99 | ▼ 17.4% |
| ICUCW | SeaStar Medical Holding Corporation | USD 0.02 | ▲ 0% |
| CDIOW | Cardio Diagnostics Holdings, Inc. | USD 0.01 | ▼ 28.09% |
| AIIOW | Robo.ai Inc. | USD 0.02 | ▲ 64.29% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt